MedPath

EFFECT OF REMIFENTANIL AND PRPOPOFOL TIMING ADMINISTRATION ON THE DEEPNESS OF HYPNOSIS. - ND

Phase 1
Conditions
PATIENTS UNDERGOING SURGERY WITH LOCOREGIONAL ANAESTHESIA AND SEDATION
MedDRA version: 9.1Level: SOCClassification code 10042613Term: Surgical and medical procedures
Registration Number
EUCTR2006-001174-25-IT
Lead Sponsor
OSPEDALE S. RAFFAELE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

PATIENTS BETWEEN 18 AND 75 YEARS OLD PROPOSED AS CANDIDATE FOR SURGERY WITH LOCO REGIONAL ANAESTHESIA
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

POLOMONAR,CARDIAC OR RENAL PATOLOGIES; SEVERE DISLIPIDEMIA; OVERDOSE OF DRUGS, ALCOOL; BODY MASS INDEX 30; PATIENTS WITH SNC DISEASE ETC.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: TO EVALUATE IF ADMINISTRATION TIMING OF THE 2 DRUGS, CAN MUTUALLY CONDITIONING THE HYPNOSI LEVEL THROUGH THE MONITORING OF THE HYPNOTIC DEPRESSANT LEVEL BY BIS BISPECTRAL INDEX .;Secondary Objective: ;Primary end point(s):
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath